Auranofin efficacy against MDR Streptococcus pneumoniae and Staphylococcus aureus infections

摘要

Background: Auranofin is an FDA-approved, gold-containing compound in clinical use for the oral treatment of rheumatoid arthritis and has been recently granted by the regulatory authorities due to its antiprotozoal properties.